1. Cutaneous T-cell Lymphoma and Concomitant Atopic Dermatitis Responding to Dupilumab
- Author
-
Ellen J. Kim, Christina A Del Guzzo, Bobak T. Pousti, Nicholas K. Mollanazar, Carmela C. Vittorio, Alain H. Rook, Paul Haun, Kevin T. Savage, and Neha Jariwala
- Subjects
medicine.medical_specialty ,Skin Neoplasms ,business.industry ,Cutaneous T-cell lymphoma ,Atopic dermatitis ,Antibodies, Monoclonal, Humanized ,medicine.disease ,Dupilumab ,Dermatology ,Dermatitis, Atopic ,Lymphoma, T-Cell, Cutaneous ,Lymphoma ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,hemic and lymphatic diseases ,030220 oncology & carcinogenesis ,Concomitant ,Psoriasis ,medicine ,Humans ,business - Abstract
Cutaneous T-cell lymphoma (CTCL) represents a diagnostic challenge because of its large symptomatic overlap with other common skin conditions such as atopic dermatitis (AD) and psoriasis. Dupilumab has offered promising results in AD treatment; however, concerns exist that its use may exacerbate undiagnosed CTCL. We present a patient with CTCL and concomitant AD who experienced improvement in both CTCL blood involvement and AD following the addition of dupilumab therapy.
- Published
- 2020